GISH BIOMEDICAL INC
10QSB, EX-27, 2000-11-14
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: ADVANCED REMOTE COMMUNICATION SOLUTIONS, 424B3, 2000-11-14
Next: GISH BIOMEDICAL INC, 10QSB, 2000-11-14



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     This Schedule  contains summary  financial  information  extracted from the
Form 10-QSB of Gish  Biomedical,  Inc., for the three months ended September 30,
2000 and is qualified in its entirety by reference to such financial statements.

</LEGEND>
<CIK>                                   0000700945
<NAME>                                  GISH BIOMEDICAL, INC.
<MULTIPLIER>                            1000


<S>                                     <C>
<PERIOD-TYPE>                           3-MOS
<FISCAL-YEAR-END>                 JUN-30-2001
<PERIOD-START>                    JUL-01-2000
<PERIOD-END>                      SEP-30-2000
<CASH>                                    461
<SECURITIES>                              685
<RECEIVABLES>                           3,329
<ALLOWANCES>                              171
<INVENTORY>                             8,040
<CURRENT-ASSETS>                       12,426
<PP&E>                                  9,673
<DEPRECIATION>                          7,512
<TOTAL-ASSETS>                         14,742
<CURRENT-LIABILITIES>                   1,745
<BONDS>                                     0
                       0
                                 0
<COMMON>                               10,532
<OTHER-SE>                              2,234
<TOTAL-LIABILITY-AND-EQUITY>           14,742
<SALES>                                 4,285
<TOTAL-REVENUES>                        4,285
<CGS>                                   3,132
<TOTAL-COSTS>                           1,704
<OTHER-EXPENSES>                            0
<LOSS-PROVISION>                            0
<INTEREST-EXPENSE>                        (51)
<INCOME-PRETAX>                          (500)
<INCOME-TAX>                                0
<INCOME-CONTINUING>                      (500)
<DISCONTINUED>                              0
<EXTRAORDINARY>                             0
<CHANGES>                                   0
<NET-INCOME>                             (500)
<EPS-BASIC>                              (.14)
<EPS-DILUTED>                            (.14)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission